Akari Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases.

CEO

Abizer Gaslightwala

CEOAbizer Gaslightwala

Employees

Employees6

Headquarters

Tampa, Florida

HeadquartersTampa, Florida

Founded

2004

Founded2004

Employees

Employees6

AKTX Key Statistics

Market cap

20.81M

Market cap20.81M

Price-Earnings ratio

-0.07

Price-Earnings ratio-0.07

Dividend yield

—

Dividend yield—

Average volume

4.06M

Average volume4.06M

High today

$19.50

High today$19.50

Low today

$8.23

Low today$8.23

Open price

$9.92

Open price$9.92

Volume

34.04M

Volume34.04M

52 Week high

$56.80

52 Week high$56.80

52 Week low

$3.02

52 Week low$3.02

AKTX News

TipRanks 3d

Akari Therapeutics Announces Private Placement of Equity Securities

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

TipRanks 3d

Akari Therapeutics Stock Explodes 242% on Strong Cancer Drug Data and $5.5M Funding Boost

Akari Therapeutics (AKTX) jumped over 241.8% on Friday. The upside came after the company released promising new preclinical data for its lead cancer drug, AKTX...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.